The development of carbamazepine-succinic acid cocrystal tablet formulations with improved in vitro and in vivo performance

References

• Aitipamula S, Wong AB, Chow PS, Tan RB. Pharmaceutical cocrystals of ethenzamide: structural, solubility and dissolution studies. Cryst Eng Comm 2012;14:8515–24.
   Web of Science ®Google Scholar
• Byrn SR, Pfeiffer RR, Stowell JG. Solid state chemistry of drugs. 2nd edn. West Lafay, IN: SSCI, Inc.; 1999.
   Google Scholar
• Stahl PH, Wermuth CG, eds. Handbook of pharmaceutical salts: properties, selection, and use. New York: Wiley-VCH; 2002.
   Google Scholar
• Serajuddin ATM. Salt formation to improve drug solubility. Adv Drug Deliv Rev 2007;59:603–16.
   PubMed Web of Science ®Google Scholar
• Vishweshwar P, McMahon JA, Bis JA, Zaworotko MJ. Pharmaceutical co-crystals. J Pharm Sci 2006;95:499–516.
   PubMed Web of Science ®Google Scholar
• Aakeroy CB, Fasulo ME, Desper J. Cocrystal or salt: does it really matter? Mol Pharm 2007;4:317–22.
   PubMed Web of Science ®Google Scholar
• Meanwell NA. The emerging utility of cocrystals in drug discovery and development. Annual Rep Med Chem 2008;43:373–404.
   Web of Science ®Google Scholar
• Sun CC. Cocrystallization for successful drug delivery. Expert Opin Drug Deliv 2013;10:201–13.
   PubMed Web of Science ®Google Scholar
• Lou B, Perumalla SR, Sun CC. Significant expansion of the solid state landscape of Salicylic acid based on charge-assisted hydrogen bonding interactions. Cryst Growth Des 2014;15:24–8.
   Web of Science ®Google Scholar
• Perumalla SR, Sun CC. Design and synthesis of solid state structures with conjugate acid–base pair interactions. Cryst Eng Comm 2012;14:3851–3.
   Web of Science ®Google Scholar
• Trask AV, Motherwell W, Jones W. Physical stability enhancement of theophylline via cocrystallization. Int J Pharm 2006;320:114–23.
   PubMed Web of Science ®Google Scholar
• Perumalla SR, Sun CC. Design and preparation of a 4:1 lamivudine-oxalic acid CAB cocrystal for improving lamivudine purification process. Cryst Growth Des 2014;14:3990–5.
   Web of Science ®Google Scholar
• Gao Y, Gao J, Liu Z, et al. Coformer selection based on degradation pathway of drugs: a case study of adefovir dipivoxil–saccharin and adefovir dipivoxil–nicotinamide cocrystals. Int J Pharm 2012;438:327–35.
   PubMed Web of Science ®Google Scholar
• Vangala VR, Chow PS, Tan RBH. Characterization, physicochemical and photo-stability of a co-crystal involving an antibiotic drug, nitrofurantoin, and 4-hydroxybenzoic acid. Cryst Eng Comm 2011;13:759–76.
   Web of Science ®Google Scholar
• Perumalla SR, Sun CC. Improved solid-state stability of salts by cocrystallization between conjugate acid–base pairs. Cryst Eng Comm 2013;15:5756–9.
   Web of Science ®Google Scholar
• McNamara DP, Childs S, Giordano J, et al. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. Pharm Res 2006;23:1888–97.
   PubMed Web of Science ®Google Scholar
• Sun CC, Hou H. Improving mechanical properties of caffeine and methyl gallate crystals by cocrystallization. Cryst Growth Des 2008;8:1575–9.
   Web of Science ®Google Scholar
• Krishna GR, Shi L, Bag PP, et al. Correlation among crystal structure, mechanical behavior, and tabletability in the co-crystals of Vanillin Isomers. Cryst Growth Des 2015;15:1827–32.
   Web of Science ®Google Scholar
• Chow SF, Chen M, Shi L, et al. Simultaneously improving the mechanical properties, dissolution performance, and hygroscopicity of Ibuprofen and Flurbiprofen by cocrystallization with Nicotinamide. Pharm Res 2012;29:1854–65.
   PubMed Web of Science ®Google Scholar
• Panakanti R, Narang AS. Impact of excipient interactions on drug bioavailability from solid dosage forms. Pharm Res 2012;29:2639–59.
   PubMed Web of Science ®Google Scholar
• Murphy D, Rodrıguez-Cintrón F, Langevin B, et al. Solution-mediated phase transformation of anhydrous to dihydrate carbamazepine and the effect of lattice disorder. Int J Pharm 2002;246:121–34.
   PubMed Web of Science ®Google Scholar
• Tian F, Zeitler J, Strachan C, et al. Characterizing the conversion kinetics of carbamazepine polymorphs to the dihydrate in aqueous suspension using Raman spectroscopy. J Pharm Biomed Anal 2006;40:271–80.
   PubMed Web of Science ®Google Scholar
• Meyer MC, Straughn AB, Jarvi EJ, et al. The bioinequivalence of carbamazepine tablets with a history of clinical failures. Pharm Res 1992;9:1612–16.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Limwikrant W, et al. Mechanistic differences in permeation behavior of supersaturated and solubilized solutions of carbamazepine revealed by nuclear magnetic resonance measurements. Mol Pharm 2012;9:3023–33.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Hornedo N, Murphy D. Surfactant-facilitated crystallization of dihydrate carbamazepine during dissolution of anhydrous polymorph. J Pharm Sci 2004;93:449–60.
   PubMed Web of Science ®Google Scholar
• Qiao N. Investigation of carbamazepine-nicotinamide cocrystal solubility and dissolution by a UV imaging system [PhD thesis]. Leicester, UK: De Monfort University; 2014
   Google Scholar
• Chan HK, Grant DJ. Influence of compaction on the intrinsic dissolution rate of modified acetaminophen and adipic acid crystals. Int J Pharm 1989;57:117–24.
   Web of Science ®Google Scholar
• Jinno J, Oh DM, Crison JR, Amidon GL. Dissolution of ionizable water-insoluble drugs: the combined effect of pH and surfactant. J Pharm Sci 2000;89:268–74.
   PubMed Web of Science ®Google Scholar
• Yu LX, Carlin AS, Amidon GL, Hussain AS. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs. Int J Pharm 2004;270:221–7.
   PubMed Web of Science ®Google Scholar
• Zakeri-Milani P, Barzegar-Jalali M, Azimi M, Valizadeh H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Eur J Pharm Biopharm 2009;73:102–6.
   PubMed Web of Science ®Google Scholar
• Østergaard J, Meng-Lund E, Larsen SW, et al. Real-time UV imaging of nicotine release from transdermal patch. Pharm Res 2010;27:2614–23.
   PubMed Web of Science ®Google Scholar
• Qiao N, Wang K, Schlindwein W, et al. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour. Eur J Pharm Biopharm 2013;83:415–26.
   PubMed Web of Science ®Google Scholar
• Hawley M, Morozowich W. Modifying the diffusion layer of soluble salts of poorly soluble basic drugs to improve dissolution performance. Mol Pharm 2010;7:1441–9.
   PubMed Web of Science ®Google Scholar
• Janssens S, Nagels S, Armas HND, et al. Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. Eur J Pharm Biopharm 2008;69:158–66.
   PubMed Web of Science ®Google Scholar
• Vandecruys R, Peeters J, Verreck G, Brewster ME. Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. Int J Pharm 2007;342:168–75.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Schuessel K, Davis A, Hadgraft J. Formation and stabilisation of triclosan colloidal suspensions using supersaturated systems. Int J Pharm 2003;261:153–8.
   PubMed Web of Science ®Google Scholar
• Simonelli A, Mehta S, Higuchi W. Inhibition of sulfathiazole crystal growth by polyvinylpyrrolidone. J Pharm Sci 1970;59:633–8.
   PubMed Web of Science ®Google Scholar
• Terayama H, Inada K, Nakayama H, et al. Preparation of stable aqueous suspension of a hydrophobic drug with polymers. Colloids Surf B Biointerfaces 2004;39:159–64.
   PubMed Web of Science ®Google Scholar
• Ueda K, Higashi K, Yamamoto K, Moribe K. The effect of HPMCAS functional groups on drug crystallization from the supersaturated state and dissolution improvement. Int J Pharm 2014;464:205–13.
   PubMed Web of Science ®Google Scholar
• Forster A, Hempenstall J, Rades T. Characterization of glass solutions of poorly water-soluble drugs produced by melt extrusion with hydrophilic amorphous polymers. J Pharm Pharmacol 2001;53:303–15.
   PubMed Web of Science ®Google Scholar
• Tsinman O, Tsinman K, Ali S. Soluplus®: An understanding of supersaturation from amorphous solid dispersions. Tablets Capsules 2010;15:20–26.
   Google Scholar
• Hardung H, Djuric D, Ali S. Combining HME & solubilization: Soluplus® – the solid solution. Drug Del Technol 2010;10:20–7.
   Google Scholar
• Tomaszewska I, Karki S, Shur J, et al. Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer. Int J Pharm 2013;453:380–8.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996;20:64–74.
   Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–33.
   PubMed Web of Science ®Google Scholar
• Mowafy HA, Alanazi FK, El Maghraby GM. Development and validation of an HPLC-UV method for the quantification of carbamazepine in rabbit plasma. Saudi Pharm J 2012;20:29–34.
   PubMed Web of Science ®Google Scholar
• Grzesiak AL, Lang M, Kim K, Matzger AJ. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci 2003;92:2260–71.
   PubMed Web of Science ®Google Scholar
• Childs SL, Rodríguez-Hornedo N, Reddy LS, et al. Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine. Cryst Eng Comm 2008;10:856–64.
   Web of Science ®Google Scholar
• Alonzo DE, Zhang GG, Zhou D, et al. Understanding the behavior of amorphous pharmaceutical systems during dissolution. Pharm Res 2010;27:608–18.
   PubMed Web of Science ®Google Scholar
• DiNunzio JC, Hughey JR, Brough C, et al. Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm 2010;36:1064–78.
   PubMed Web of Science ®Google Scholar
• Alshahrani SM, Lu W, Park JB, et al. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF. AAPS Pharm Sci Tech 2015;16:824–34.
   PubMed Web of Science ®Google Scholar